This pioneering mouse model replicates the key characteristics of hypoplastic left heart syndrome by exhibiting an underdeveloped aorta and left ventricle, along with defective aortic and mitral valves. It demonstrates a unique cardiac arrangement where the right ventricle compensates for the impaired left, channeling blood through a patent ductus arteriosus with an accompanying atrial septal defect that permits mixing of oxygenated and deoxygenated blood. The methodology integrates traditional forward genetics with CRISPR-Cas9 validation, ensuring the model confidently mimics the human condition through rigorous in vivo testing.